retatrutide type 2 diabetes phase 2 results 2024 2025 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 trial shows. is part of an emerging generation Effects of retatrutide on body

A total of 6,068 participants with T2DM, history of myocardial infarction or unstable angina, average baseline HbA1c of 7.7%, and a median follow-up of 25 months was enrolled

Preclinical studies have validated the therapeutic potential of these compounds for the treatment of obesity and diabetes

[1] Healthcare providers may need to adjust the dosages of these concomitant medications to mitigate the risk of hypoglycemia

In August 2025, Judge Karen Spencer Marston instructed plaintiffs to support gastroparesis allegations with objective gastric emptying tests

Both medications have shown strong results for weight management